|
|
|
| CDMO Services: Customized Lipids & LNP Solutions | Bringing your lipid-based therapies from early research into clinical and commercial manufacturing demands more than technical capability. It requires experience, flexibility, and seamless execution across development stages. Explore GMP-ready, fully connected CDMO services: From lipid manufacturing through LNP formulation, manufacturing, and Fill & Finish. In this infographic, you will discover flexible collaboration models tailored to your path, pace, and evolving program needs. Download now to learn more! |
|
|
|
|
By Anna Rose Welch, editorial & community director, Advancing RNA | To be clear, this year’s USP/AMM quality forum was just as focused on the intricacies of applying/using the methods. But what was equally if not more present in this year’s discussion was our increasing acknowledgement that our understanding of mRNA and its biological mechanisms remains quite messy. | |
|
|
|
RNA Modification-Mediated Translational Control In Immune Cells | By Hua-Bing Li, Ph.D., Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine | Exploring how m6A RNA modifications control immune cell translation, influencing inflammation, tumor immunity, T cell activation, and future immunotherapies. |
|
|
|
|
|
| Levers To Optimize The IVT Reaction For Increased mRNA Yield | Application Note | By Alexander Latta, Neera Sammeta, et al., Roche CustomBiotech | Mastering IVT yield requires balancing magnesium and nucleotide ratios. Learn how specific buffers and pyrophosphatase optimize mRNA synthesis for scalable, high-quality therapeutic production. |
|
|
|
| Nucleic Acid-LNP Ultrafiltration And Diafiltration | White Paper | Recipharm Advanced Bio | Downstream filtration can make or break LNPs at scale. See how membrane format, loading, and shear affect recovery and stability — and how alternative TFF lowers scale‑up risk. |
|
|
| Unlocking The Next Wave Of Cancer Vaccines | Webinar | Cytiva | Explore how advanced ionizable LNP formulations and scalable manufacturing strategies can accelerate the development and clinical translation of personalized cancer vaccines. |
|
|
|
|
| RNA Leaders USA is the go-to event for advancing RNA therapeutics. Connect with leading experts, explore new ideas, and gain practical insights into the latest RNA developments. Whether you're driving innovation or looking to stay ahead, this event is not to be missed. Join the conversation shaping the future of RNA! |
|
|
|
|
|
|
|
|
|
| Join 90+ global experts at the 5th Oligonucleotide Analytical Development & CMC Summit (Aug 17–19, Boston) to tackle the industry’s most pressing challenges in analytical characterization, impurity control, and scalable manufacturing. Gain practical insights from leading biopharma, biotech, and regulatory voices advancing oligo therapeutics across ASO, siRNA, and conjugate modalities. Explore the agenda and secure your place soon. |
|
|
.png){kind=logo}
